Medications

Q&A: Experts discuss pros, cons of new Alzheimer's drug

Patient care teams are preparing to offer lecanemab, a new Alzheimer's disease treatment expected to soon receive approval from the U.S. Food and Drug Administration (FDA), to patients in the coming months.

Diseases, Conditions, Syndromes

Hepatitis C can kill, but too many can't access the cure

More than 2 million people in the United States have hepatitis C, but most are not getting the safe treatment that can cure the disease, public health officials said Thursday.

page 2 from 9